AR012187A1 - Composicion farmaceutica libre de lactosa que contiene noratemizol como agente activo, formas de dosificacion que contiene dicha composicion y metodopara el tratamiento de desordenes alergicos con aplicacion de dicha composicion - Google Patents

Composicion farmaceutica libre de lactosa que contiene noratemizol como agente activo, formas de dosificacion que contiene dicha composicion y metodopara el tratamiento de desordenes alergicos con aplicacion de dicha composicion

Info

Publication number
AR012187A1
AR012187A1 ARP980101398A ARP980101398A AR012187A1 AR 012187 A1 AR012187 A1 AR 012187A1 AR P980101398 A ARP980101398 A AR P980101398A AR P980101398 A ARP980101398 A AR P980101398A AR 012187 A1 AR012187 A1 AR 012187A1
Authority
AR
Argentina
Prior art keywords
composition
treatment
noratemizol
active agent
dosage forms
Prior art date
Application number
ARP980101398A
Other languages
English (en)
Original Assignee
Sepracor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sepracor Inc filed Critical Sepracor Inc
Publication of AR012187A1 publication Critical patent/AR012187A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Se trata de composiciones farmacéuticas, química y térmicamente estables, formuladas con un potente antihistamínico de formula I denominado norastemizol.Dichas composicones están exentas de lactosa, no son higroscopicas, y se presentan en forma anhidra, en partículas grandes o recubiertas, denorastemizol o sales farmacéuticamente aceptables del mismo, de simple fabricacion. También se proponen métodos para el tratamiento de estadosalérgicos.
ARP980101398A 1997-03-26 1998-03-26 Composicion farmaceutica libre de lactosa que contiene noratemizol como agente activo, formas de dosificacion que contiene dicha composicion y metodopara el tratamiento de desordenes alergicos con aplicacion de dicha composicion AR012187A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82447797A 1997-03-26 1997-03-26
US85178697A 1997-05-06 1997-05-06

Publications (1)

Publication Number Publication Date
AR012187A1 true AR012187A1 (es) 2000-09-27

Family

ID=27124816

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980101398A AR012187A1 (es) 1997-03-26 1998-03-26 Composicion farmaceutica libre de lactosa que contiene noratemizol como agente activo, formas de dosificacion que contiene dicha composicion y metodopara el tratamiento de desordenes alergicos con aplicacion de dicha composicion

Country Status (13)

Country Link
EP (1) EP1035869A1 (es)
JP (1) JP2002512614A (es)
KR (1) KR20010005746A (es)
CN (1) CN1257431A (es)
AR (1) AR012187A1 (es)
BR (1) BR9808428A (es)
CA (1) CA2284705A1 (es)
HU (1) HUP0001823A3 (es)
NO (1) NO994655L (es)
NZ (3) NZ527200A (es)
RU (1) RU2214245C2 (es)
WO (1) WO1998042379A2 (es)
ZA (1) ZA982562B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ289261B6 (cs) * 2000-07-11 2001-12-12 Léčiva, A.S. Tableta vyrobitelná přímým tabletováním, obsahující aktivní látku kyselinu 4-amino-1-hydroxybutyliden-1,1-bisfosfonovou, a způsob její výroby
EP2201982A1 (en) * 2008-12-24 2010-06-30 INSERM (Institut National de la Santé et de la Recherche Médicale) Histamine H4 receptor antagonists for the treatment of vestibular disorders
WO2011024028A1 (en) * 2009-08-24 2011-03-03 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi Direct compression tablets of otilonium

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0232937B1 (en) * 1986-02-03 1992-08-19 Janssen Pharmaceutica N.V. Anti-histaminic compositions containing n-heterocyclyl-4-piperidinamines
DE4037426A1 (de) * 1990-11-24 1992-05-27 Kali Chemie Pharma Gmbh Piperidinoalkylbenzoxazin- und -thiazin-verbindungen sowie verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
CA2143610C (en) * 1992-09-03 2004-08-24 Raymond L. Woosley Use of norastemizole for the treatment of allergic disorders
ATE232858T1 (de) * 1995-11-17 2003-03-15 Aventis Pharma Inc Substituierte 4-(1h-benzimidazol-2-yl- amino)piperidine zur behandlung allergischer erkrankungen
CA2263163A1 (en) * 1996-08-16 1998-02-19 Schering Corporation Treatment of upper airway allergic responses with a combination of histamine receptor antagonists

Also Published As

Publication number Publication date
HUP0001823A2 (hu) 2001-04-28
JP2002512614A (ja) 2002-04-23
NO994655L (no) 1999-11-15
CA2284705A1 (en) 1998-10-01
NZ527200A (en) 2004-12-24
EP1035869A1 (en) 2000-09-20
KR20010005746A (ko) 2001-01-15
WO1998042379A3 (en) 2001-03-01
AU735257B2 (en) 2001-07-05
HUP0001823A3 (en) 2002-04-29
AU6868098A (en) 1998-10-20
BR9808428A (pt) 2000-05-23
RU2214245C2 (ru) 2003-10-20
NZ517472A (en) 2003-08-29
ZA982562B (en) 1998-10-01
NO994655D0 (no) 1999-09-24
CN1257431A (zh) 2000-06-21
NZ527201A (en) 2004-12-24
WO1998042379A2 (en) 1998-10-01

Similar Documents

Publication Publication Date Title
AR018109A1 (es) FORMULACIoN GALÉNICA ADMINISTRABLE POR VíA ORAL QUE PERMITE UNA ABSORCIoN MEJORADA DE PRINCIPIOS ACTIVOS, USO DE UN AGENTE MAJORADOR DE ABSORCIoN PARA PREPARAR UNA FORMA DE DOSIFICACIoN ADMINISTRABLE POR VíA ORAL Y PROCEDIMIENTO PARA PREPARAR DICHA FORMULACIoN GALÉNICA
AR046933A1 (es) Eficacia de humectacion mejorada mediante el uso de hidroxialquilurea
GT199900203A (es) Composiciones de celecoxib.
CY1107925T1 (el) Διαλυμα για εφαρμογη στα νυχια
CL2008002407A1 (es) Forma de dosificacion oral que comprende al menos un agente activo de nicotina, al menos un material bioadhesivo capaz de formar un enlace de hidrogeno con el agente activo de nicotina, y al menos un agente de impacto sensorial que se libere rapidamente; y su uso para proporcionar alivio rapido de las ansias de nicotina (div. sol. 1825-04).
BRPI0513864A (pt) compostos, processo para a sua manufatura, composições farmacêuticas que os compreendem, sua utilização e método para o tratamento e/ou profilaxia de enfermidades
MX9202407A (es) Composicion farmaceutica que contiene un compuesto de alilamina como el agente activo y proceso para su preparacion.
SE0102438D0 (sv) New compounds
AR053541A1 (es) Combinacion de xolair con agente inmunosupresor
CO4440476A1 (es) Composicion sinergistica que comprende una combinacion plaguicida de ingredientes activos .
DE60134245D1 (de) (5-(2-hydroxy-4-chlorbenzoyl)valeriansäure und deren salze, und zusammensetzungen zur zuführung von wirkstoffen, die diese verbindungen enthalten
AR034900A1 (es) Uso de una cantidad eficaz de un inhibidor de pde4 y un agente anticolinergico, bien en forma combinada sola o por separado, composiciones farmaceuticas que los comprenden, metodo para prepararlas, y uso de una composicion que comprende una cantidad eficaz de un inhibidor de pde4, una cantidad efica
BR9814923A (pt) Método para tratamento de doença de alzheimer
FI964285A (fi) Taksaanien luokkaan kuuluviin johdannaisiin perustuvat farmaseuttiset valmisteet
ATE287267T1 (de) Kombinationstherapien mit gefässschädigender aktivität
ECSP034826A (es) Método para fabricar una composición farmacéutica de dosis baja
BR9809022A (pt) Composições antiinflamatórias nasais tópicas
FR2816507B1 (fr) Microgranules a base de principe actif, procede de fabrication et compositons pharmaceutiques integrant lesdits microgranules
BR0306732A (pt) Tratamentos em combinação para doença alérgica compreendendo a administração de um anticorpo anti-ige e composto antialérgico
DK1280558T3 (da) Halvfast indgivelsesvehikel og farmaceutiske sammensætninger
AR012187A1 (es) Composicion farmaceutica libre de lactosa que contiene noratemizol como agente activo, formas de dosificacion que contiene dicha composicion y metodopara el tratamiento de desordenes alergicos con aplicacion de dicha composicion
DE69919597D1 (de) Topische formulierungen, die hautpenetrations-mittel enthalten, und ihre verwendung
ES2150404T3 (es) Composiciones farmaceuticas de tizoxanida y nitozoxanida.
SE0000303D0 (sv) Novel compounds
AR026705A1 (es) Forma triturada

Legal Events

Date Code Title Description
FB Suspension of granting procedure